Mounjaro®
Starting from £179.99/mo
Start journey Learn moreFor most people, the side effects of Wegovy do settle. Nausea, loose stools and fatigue are most noticeable in the first few weeks after starting or increasing a dose, and they typically ease as the body adjusts to semaglutide. A small number of people experience side effects that persist longer or are more troublesome, which is why ongoing clinical support matters throughout treatment. Wegovy is a prescription-only medicine requiring a proper clinical assessment before it is prescribed; a prescriber can help you understand which effects are expected and transient, and which need attention.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The first four to eight weeks tend to be when side effects are loudest. Semaglutide slows the movement of food through the stomach, which triggers nausea in many people, along with burping, indigestion, and sometimes vomiting. According to the NHS guidance on semaglutide, these gastrointestinal effects are the most commonly reported, and they are usually mild to moderate rather than severe.
The graduated dose schedule exists precisely for this reason. Starting at 0.25 mg gives the body time to acclimatise before the dose climbs. Most people find nausea peaks in the day or two after their injection, then fades before the next one. Eating smaller portions, avoiding rich or fatty meals, and staying hydrated all help. One misconception worth setting aside: many people assume this nausea means something is wrong, or that the medicine is not suited to them. Usually it simply means the dose is doing what it is supposed to do, and the body needs a little time.
Fatigue is less talked about but genuinely common in early weeks. If you want more detail on how tiredness tends to progress, the page on whether Wegovy fatigue goes away covers it specifically. The short answer: for most people, energy levels recover once the initial adjustment settles.
One thing that catches people out is that side effects can resurface briefly each time the dose goes up. This is not a sign that treatment has stopped working or that tolerance has been lost. It is the same adjustment process repeating at a slightly higher level. The pattern tends to be milder each time, and shorter.
The licensed titration for Wegovy moves through 0.25 mg, 0.5 mg, 1.0 mg, 1.7 mg and up to 2.4 mg, with roughly four weeks at each level. That gradual staircase is deliberately designed to limit GI burden. If a particular step causes persistent or difficult side effects, a prescriber can slow the titration, staying at a lower dose for longer before moving up. This is a clinical decision, and it is one of the most useful adjustments available. The timeline for how long side effects typically last varies by individual, but the adjustment window at each step is usually shorter than the one before.
Diarrhoea is worth a separate mention because it can be dehydrating. The question of whether Wegovy-related diarrhoea resolves is one our prescribers hear regularly, the evidence suggests it does for most people, but hydration matters in the meantime.
Once someone has been on their maintenance dose for several weeks, many of the early GI symptoms quiet down considerably. Appetite reduction, which is the intended effect, tends to remain. Some people notice mild nausea persisting if they eat too quickly or too much, but this is usually manageable rather than distressing. Constipation can be an ongoing feature for some people; increasing dietary fibre and fluid intake helps, and it is worth raising with a prescriber if it becomes problematic.
The full side-effect profile for Wegovy includes injection-site reactions (redness, discomfort at the injection spot), which are common but typically minor and short-lived. Headache and dizziness also appear in trial data but tend to be early-treatment effects that do not persist. The STEP 1 trial, published in the New England Journal of Medicine, reported that most adverse events leading to discontinuation were GI in nature and occurred in the first months of treatment, supporting the picture that they cluster early.
For a broader view of semaglutide's tolerability profile across both injection and oral forms, the comparison of semaglutide side-effect timelines is worth reading alongside this page.
Most side effects are inconvenient, not dangerous. Some are neither. Seek urgent medical attention for: severe stomach pain that radiates into your back, with or without vomiting, this can indicate acute pancreatitis, which the MHRA highlighted in a Drug Safety Update in January 2026 as an infrequent but serious risk with GLP-1 medicines. Also seek help promptly for signs of a gallbladder problem (sharp pain in the upper right abdomen), severe dehydration from persistent vomiting or diarrhoea, any allergic reaction (swelling of the face, lips or throat, difficulty breathing), or significant low mood or thoughts of self-harm.
These are not reasons to avoid treatment. They are reasons to stay in contact with your clinical team throughout it. At nume, our prescribers are available for aftercare seven days a week, and every repeat order is individually reviewed before being dispensed. If you have questions about how side effects are managed in practice, our team is reachable through the support page. You can also check your eligibility and discuss suitability as part of the free initial consultation, side effects, your health history and any concerns are part of that conversation, not an afterthought.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.